First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Does your pharmacy program have strategies in place to manage physician dispensed medications, such as dermatologicals and other high-cost products
Initial diagnosis and recovery doesn’t mean the end of dreaded virus Post-COVID conditions is the CD
Quality medical care starts with quality ingredients • Accurate provider information • Strong provider relationships
The average number of baby boomers who retire from the U.S.
People suffering with lingering symptoms after having COVID-19 may be covered under the Americans with Disabilities Act.
Presented by: Tammy Bradly, VP Clinical Product Development